Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TUG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR4A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBL1X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VIPAS39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3R3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC61G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C6orf106 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on